(A) Experimental model for neonatal hyperoxia followed by IAV infection: C57Bl6 pups aged <12 hr were exposed to either hyperoxia (>95% O2) or room air (21% O2) from PN0–5. Thereafter, the pups were …
Source data for Figure 1.
Thereafter, the animals were allowed to recover in room air and acclimatized to revere light–dark cycles for 3–4 weeks. Mice were infected with 25–40 PFU of PR8 at either ZT23 (dawn or just before …
After the 5 day neonatal hyperoxia exposure, body weight of both the hyperoxia-exposed mice and their room air littermates were measured at 4 weeks and at 8 weeks as a measure of overall well-being …
Mice pups <12 hr old were exposed to either hyperoxia or room air for 5 days and then recovered in RA into adulthood. As adults, effect on the central (locomotor activity) and peripheral (gene …
Source data for Figure 2.
(A) Flow cytometric enumeration of the CD45+ cells from lungs of adult mice exposed to neonatal hyperoxia or room air (n = 5–7/group from three independent experiments). (B) Viral burden measure by …
Criteria for scoring lung injury on histology.
Source data for Figure 3.
(A) Gene expression of clock genes from whole lungs harvested at 6 hr intervals determined by qPCR (n = 4–6 per time point from three different experiments). (B) Representative bioluminescence …
Source data for Figure 4.
qPCR primers used to generate data for Figure 4.
Experimental design: SftpcCreERt2/+::Bmal1fl/fl mice (mice lacking Bmal1 in AT2 cells of the lung epithelium) and their creneg littermates were treated with tamoxifen at 6–8 weeks of age and …
Source data for Figure 5.
(n = 5–8/group).
(A) Whole lung gene expression measured by qPCR on day 5 post-infection in adults exposed to neonatal hyperoxia or room air (left panel) and SftpcCreERt2/+::Bmal1fl/fl mice (mice lacking Bmal1 in …
Source data for Figure 6.
Reagent type (species) or resource | Designation | Source or reference | Identifiers | Additional information |
---|---|---|---|---|
Antibody | Anti-Bmal1 (Rabbit monoclonal) | Abcam | ab230822 | IF(1:1000) |
Antibody | anti-Pro-SPC (Rabbit polyclonal) | EMD Millipore | ab3786 | IF(1:2000) |
Antibody | Nk1.1 (Mouse monoclonal) | Biolegend | 108716 | Flow cytometry (1:100) |
Antibody | Ly6C (Mouse monoclonal) | Biolegend | 128024 | Flow cytometry (1:100) |
Antibody | CD45 (Rat monoclonal) | Biolegend | 103114 | Flow cytometry (1:100) |
Antibody | CD11c (Hamster monoclonal) | Biolegend | 117324 | Flow cytometry (1:100) |
Antibody | CD11b (Mouse monoclonal) | EBiosciences | 11-0112-41, 47-0112-82 | Flow cytometry (1:100) |
Antibody | CD3 (Rat monoclonal) | EBiosciences | 11-0032-82 | Flow cytometry (1:50) |
Antibody | Ly6G (Rat monoclonal) | Biolegend | 127606, 127608, | Flow cytometry (1:100) |
Antibody | Siglec F (Rat monoclonal) | BD Pharmingen | 552126 | Flow cytometry (1:100) |
Software Algorithm | Clocklab | Actimetrics | Rest-activity analyses | |
Other | DAPI stain | D1306 | (1 µg/mL) | |
Chemicals strain, strain background (include species and sex here) | Tamoxifen | Sigma | T5648-1G | |
Strain, strain background (include species and sex here) | C57BL/6J | Jax | Stock No: 000664 | B6 | Both genders and age at infection > 8 weeks |